DÄ internationalArchive26/2008Congenital and Acquired Polycythemias: Radioactive Phosphorus in Polycythemia Vera Therapy

Correspondence

Congenital and Acquired Polycythemias: Radioactive Phosphorus in Polycythemia Vera Therapy

Dtsch Arztebl Int 2008; 105(26): 480; DOI: 10.3238/arztebl.2008.0480a

Schmidt, M

LNSLNS The article provides a useful overview of diagnosis and therapy of polycythemia rubra vera, among others. However, no mention was made of the therapeutic option of radioactive phosphorus-32. Although this nuclear medical treatment has not been administered to a great extent, it is well tolerated by patients if the indication is defined accordingly. Moreover, it is uncomplicated to administer. I am interested to find out why this therapeutic option was left out from the review article (1, 2).
DOI: 10.3238/arztebl.2008.0480a

PD Dr. med. Matthias Schmidt
Universitätsklinikum Köln
Klinik und Poliklinik für Nuklearmedizin
Kerpener Str. 62, 50937 Köln, Germany
nuklearmedizin@uk-koeln.de
1.
Hautzel H: 32Phosphor-Therapie der Polycythaemia vera. In: Krause BJ, Buck AK, Schwaiger M (eds): Nuklearmedizinische Onkologie. Landsberg: Verlagsgruppe Hüthig Jehle Rehm GmbH, ecomed Medizin 2007: 687–93.
2.
Nilsson S, Westlin J-E: Phosphorus-32 therapy in myeloproliferative disease. In: Ell PJ, Gamghir SS (Eds): Nuclear medicine in clinical diagnosis and treatment. Edingburgh: Churchill Libingstone 2004: 403–5.
1. Hautzel H: 32Phosphor-Therapie der Polycythaemia vera. In: Krause BJ, Buck AK, Schwaiger M (eds): Nuklearmedizinische Onkologie. Landsberg: Verlagsgruppe Hüthig Jehle Rehm GmbH, ecomed Medizin 2007: 687–93.
2. Nilsson S, Westlin J-E: Phosphorus-32 therapy in myeloproliferative disease. In: Ell PJ, Gamghir SS (Eds): Nuclear medicine in clinical diagnosis and treatment. Edingburgh: Churchill Libingstone 2004: 403–5.